Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtech Groups To Blitz Congress Before Expected House Device Tax Vote

Executive Summary

After Minnesota Congressman Erik Paulsen seemed to confirm plans for a floor vote on the medical device excise tax repeal before August, medical device lobby groups say they are rallying to get the deal done before it gets pushed off the agenda by the upcoming US Supreme Court nomination process.

You may also be interested in...



Medtech Industry Groups Spend Millions In 2019 Lobbying For Device-Tax Repeal – And Much More

Industry trade groups spend millions of dollars and walk thousands of steps in the halls of the US Congress each year to persuade legislators and their staff to support votes on device-tax repeal, Medicare payment reform, and other issues. Using lobbying reports downloaded by a public interest group, Medtech Insight has analyzed what industry spent and paid out to hire legislative experts to lobby Congress in the first half of 2019, and which topics they lobbied for the most.

If Cadillac Tax Can Be Repealed By Congress, So Can Device Tax, AdvaMed Says

The industry trade group AdvaMed recently pointed to the 17 July US House passage of a bill to repeal the Affordable Care Act’s Cadillac tax as a pathway for repealing the device tax.

AdvaMed's Top Hill Strategist JC Scott Departs; Greg Crist Will Fill Role

Greg Crist, the top public affairs executive at AdvaMed, is stepping in to head the trade group's government affairs operations, as JC Scott departs to lead the Pharmaceutical Care Management Association.

Related Content

Topics

UsernamePublicRestriction

Register

MT122923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel